Generic Name
Tadalafil
Brand Names
Cialis, Opsynvi, Tadliq, ALYQ, Adcirca
FDA approval date: November 26, 2003
Classification: Phosphodiesterase 5 Inhibitor
Form: Tablet, Suspension
What is Cialis (Tadalafil)?
CIALIS ® is a phosphodiesterase 5 inhibitor indicated for the treatment of: erectile dysfunction .
Approved To Treat
Related Clinical Trials
Actual Use Trial to Switch Tadalafil 5 mg Tablets From Prescription to Over-the-Counter
Summary: The purpose of this actual use trial (AUT) is to evaluate if participants can appropriately select and use the study product \[Cialis over the counter (OTC)\] using the labeling and the mandatory health survey assessment (HSA) for duration of 4-months.
Efficacy of Phosphodiesterase Type 5 Inhibitors in Severe Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease
Summary: ERASE PH-COPD is a randomized double-blind study, with 2 parallel groups. Patients with severe pulmonary hypertension due to chronic obstructive pulmonary disease, will be randomly assigned to receive Tadalafil orally or placebo.
Tadalafil Combined with Low-Energy Pulsed Ultrasound (LIPUS) for the Treatment of Erectile Dysfunction: a Prospective, Randomized Controlled Clinical Trial
Summary: This study aims to evaluate the clinical efficacy and histological changes of tadalafil combined with low-intensity pulsed ultrasound (LIPUS) in patients with erectile dysfunction (ED) through a randomized controlled trial.
Related Latest Advances
Save this treatment for later
Not sure about your diagnosis?
Tired of the same old research?